M.D. Melamed

1.3k total citations
24 papers, 1.2k citations indexed

About

M.D. Melamed is a scholar working on Radiology, Nuclear Medicine and Imaging, Hematology and Immunology. According to data from OpenAlex, M.D. Melamed has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Hematology and 11 papers in Immunology. Recurrent topics in M.D. Melamed's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Blood groups and transfusion (11 papers) and Glycosylation and Glycoproteins Research (9 papers). M.D. Melamed is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Blood groups and transfusion (11 papers) and Glycosylation and Glycoproteins Research (9 papers). M.D. Melamed collaborates with scholars based in United Kingdom, United States and Sweden. M.D. Melamed's co-authors include N. C. Hughes‐Jones, K. M. Thompson, Steven C. Ley, John Gordon, Michael Landon, Emil L. Smith, B.D. Gorick, T. Gibson, Pierre Åman and G. Barden and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

M.D. Melamed

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.D. Melamed United Kingdom 16 484 457 419 322 208 24 1.2k
Nancy A. Cochran United States 10 543 1.1× 265 0.6× 93 0.2× 852 2.6× 105 0.5× 11 1.5k
M Jokinen Finland 12 198 0.4× 124 0.3× 351 0.8× 613 1.9× 356 1.7× 16 1.1k
Jerry Liao United States 16 1.1k 2.3× 180 0.4× 146 0.3× 754 2.3× 68 0.3× 20 1.8k
Hisako Sakiyama Japan 18 329 0.7× 74 0.2× 82 0.2× 496 1.5× 109 0.5× 42 937
William J. Mawby United Kingdom 22 206 0.4× 97 0.2× 605 1.4× 553 1.7× 824 4.0× 29 1.3k
M Błaszczyk United States 16 402 0.8× 678 1.5× 118 0.3× 1.0k 3.2× 75 0.4× 29 1.4k
André Van Agthoven United States 14 917 1.9× 515 1.1× 156 0.4× 405 1.3× 87 0.4× 16 1.4k
Kevin M. Bean United States 8 461 1.0× 114 0.2× 120 0.3× 463 1.4× 49 0.2× 8 1.1k
Michel Fougereau France 21 666 1.4× 559 1.2× 165 0.4× 467 1.5× 46 0.2× 47 1.1k
Peter R. Blier United States 10 361 0.7× 337 0.7× 112 0.3× 641 2.0× 30 0.1× 14 1.1k

Countries citing papers authored by M.D. Melamed

Since Specialization
Citations

This map shows the geographic impact of M.D. Melamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.D. Melamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.D. Melamed more than expected).

Fields of papers citing papers by M.D. Melamed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.D. Melamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.D. Melamed. The network helps show where M.D. Melamed may publish in the future.

Co-authorship network of co-authors of M.D. Melamed

This figure shows the co-authorship network connecting the top 25 collaborators of M.D. Melamed. A scholar is included among the top collaborators of M.D. Melamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.D. Melamed. M.D. Melamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melamed, M.D., Freda K. Stevenson, Caroline Chapman, et al.. (1999). A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1. Human Antibodies. 9(2). 95–106. 10 indexed citations
2.
Thompson, K. M., et al.. (1992). Human monoclonal antibodies specific for blood group antigens demonstrate multispecific properties characteristic of natural autoantibodies.. PubMed. 76(1). 146–57. 29 indexed citations
3.
Thompson, K. M., Janet Sutherland, G. Barden, et al.. (1991). Human Monoclonal Antibodies against Blood Group Antigens Preferentially Express a VH4‐21 Variable Region Gene‐Associated Epitope. Scandinavian Journal of Immunology. 34(4). 509–518. 89 indexed citations
4.
Thompson, K. M., et al.. (1991). Human monoclonal antibodies to human blood group antigens Kidd Jka and Jkb. Transfusion Medicine. 1(2). 91–96. 6 indexed citations
5.
Lomas, C., Patricia Tippett, K. M. Thompson, M.D. Melamed, & N. C. Hughes‐Jones. (1989). Demonstration of Seven Epitopes on the Rh Antigen D Using Human Monoclonal Anti‐D Antibodies and Red Cells from D Categories. Vox Sanguinis. 57(4). 261–264. 86 indexed citations
6.
Melamed, M.D., et al.. (1989). Monoclonal antibodies. Current Opinion in Immunology. 1(5). 929–936. 1 indexed citations
7.
Gorick, B.D., et al.. (1988). Three Epitopes on the Human Rh Antigen D Recognized by 125I‐Labelled Human Monoclonal IgG Antibodies. Vox Sanguinis. 55(3). 165–170. 45 indexed citations
8.
Wiener, Edith, et al.. (1988). Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.. PubMed. 65(2). 159–63. 53 indexed citations
9.
10.
Melamed, M.D., K. M. Thompson, T. Gibson, & N. C. Hughes‐Jones. (1987). Requirements for the establishment of heterohybridomas secreting monoclonal human antibody to rhesus (D) blood group antigen. Journal of Immunological Methods. 104(1-2). 245–251. 54 indexed citations
11.
Wiener, Edith, et al.. (1987). Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their ability to mediate red cell-binding to macrophages.. PubMed. 62(3). 401–4. 52 indexed citations
12.
Thompson, K. M., M.D. Melamed, B.D. Gorick, et al.. (1986). Production of human monoclonal IgG and IgM antibodies with anti-D (rhesus) specificity using heterohybridomas.. PubMed. 58(1). 157–60. 71 indexed citations
13.
Thompson, Keith M., David W. Hough, Peter J. Maddison, M.D. Melamed, & N. C. Hughes‐Jones. (1986). The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner. Journal of Immunological Methods. 94(1-2). 7–12. 97 indexed citations
14.
Gordon, J, M.D. Melamed, Steven C. Ley, & N. C. Hughes‐Jones. (1984). Anti-immunoglobulin inhibits DNA synthesis in Epstein-Barr virus-transformed lymphoblastoid cell lines.. PubMed. 52(1). 79–85. 9 indexed citations
15.
Gordon, John, Steven C. Ley, M.D. Melamed, Pierre Åman, & N. C. Hughes‐Jones. (1984). Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus.. The Journal of Experimental Medicine. 159(5). 1554–1559. 108 indexed citations
16.
Gordon, John, et al.. (1984). Immortalized B lymphocytes produce B-cell growth factor. Nature. 310(5973). 145–147. 161 indexed citations
17.
Melamed, M.D.. (1976). Amino acid sequence of the pFc′ fragment of guinea-pig IgG1. Immunochemistry. 13(3). 271–279. 7 indexed citations
18.
Melamed, M.D.. (1972). Carboxyl terminal amino acid sequence of guinea pig γ1G. Immunochemistry. 9(12). 1233–1238. 4 indexed citations
19.
Leslie, R. G. Q., M.D. Melamed, & S. Cohen. (1971). The products from papain and pepsin hydrolyses of guinea-pig immunoglobulins γ1G and γ2G. Biochemical Journal. 121(5). 829–837. 27 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy A. Cochran Breakdown of academic impact, for papers by M Jokinen Breakdown of academic impact, for papers by Jerry Liao Breakdown of academic impact, for papers by Hisako Sakiyama Breakdown of academic impact, for papers by William J. Mawby Breakdown of academic impact, for papers by M Błaszczyk Breakdown of academic impact, for papers by André Van Agthoven Breakdown of academic impact, for papers by Kevin M. Bean Breakdown of academic impact, for papers by Michel Fougereau Breakdown of academic impact, for papers by Peter R. Blier
Rankless by CCL
2026